These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34904368)

  • 21. Prospective predictors of decline
    Hamilton CA; Matthews FE; Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; McKeith IG; Thomas AJ
    Psychol Med; 2021 Nov; 51(15):2590-2598. PubMed ID: 32366348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding heterogeneity in older adults: Latent growth curve modeling of cognitive functioning.
    MacAulay RK; Calamia MR; Cohen AS; Daigle K; Foil H; Brouillette R; Bruce-Keller AJ; Keller JN
    J Clin Exp Neuropsychol; 2018 Apr; 40(3):292-302. PubMed ID: 28669314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression.
    Beck IR; Schmid NS; Berres M; Monsch AU
    Int J Geriatr Psychiatry; 2014 Jun; 29(6):624-34. PubMed ID: 24227657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time.
    Hayden KM; Jones RN; Zimmer C; Plassman BL; Browndyke JN; Pieper C; Warren LH; Welsh-Bohmer KA
    Alzheimer Dis Assoc Disord; 2011; 25(2):128-37. PubMed ID: 21606904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
    Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early diagnosis of mild cognitive impairment and Alzheimer's with event-related potentials and event-related desynchronization in N-back working memory tasks.
    Fraga FJ; Mamani GQ; Johns E; Tavares G; Falk TH; Phillips NA
    Comput Methods Programs Biomed; 2018 Oct; 164():1-13. PubMed ID: 30195417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychological tests for predicting cognitive decline in older adults.
    Baerresen KM; Miller KJ; Hanson ER; Miller JS; Dye RV; Hartman RE; Vermeersch D; Small GW
    Neurodegener Dis Manag; 2015; 5(3):191-201. PubMed ID: 26107318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An approach for estimating item sensitivity to within-person change over time: An illustration using the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog).
    Dowling NM; Bolt DM; Deng S
    Psychol Assess; 2016 Dec; 28(12):1576-1585. PubMed ID: 27046272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of hearing loss and vestibular decline on cognition in Alzheimer's disease: a prospective longitudinal study protocol (Gehoor, Evenwicht en Cognitie, GECkO).
    Bosmans J; Jorissen C; Cras P; Van Ombergen A; Engelborghs S; Gilles A; Princen E; Moyaert J; Mertens G; Van Rompaey V
    BMJ Open; 2020 Sep; 10(9):e039601. PubMed ID: 32948575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Confirmatory factor analysis of the ADNI Neuropsychological Battery.
    Park LQ; Gross AL; McLaren DG; Pa J; Johnson JK; Mitchell M; Manly JJ;
    Brain Imaging Behav; 2012 Dec; 6(4):528-39. PubMed ID: 22777078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.
    Müller S; Herde L; Preische O; Zeller A; Heymann P; Robens S; Elbing U; Laske C
    Sci Rep; 2019 Mar; 9(1):3543. PubMed ID: 30837580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion.
    Hessen E; Kirsebom BE; Eriksson CM; Eliassen CF; Nakling AE; Bråthen G; Waterloo KK; Aarsland D; Fladby T
    J Alzheimers Dis; 2019; 67(2):715-723. PubMed ID: 30614807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Latent Structure and Test-Retest Stability of Connected Language Measures in the Wisconsin Registry for Alzheimer's Prevention (WRAP).
    Mueller KD; Koscik RL; Clark LR; Hermann BP; Johnson SC; Turkstra LS
    Arch Clin Neuropsychol; 2018 Dec; 33(8):993-1005. PubMed ID: 29186313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognition in MCI and Alzheimer's disease: baseline data from a longitudinal study of the NTB.
    Harrison J; Rentz DM; McLaughlin T; Niecko T; Gregg KM; Black RS; Buchanan J; Liu E; Grundman M;
    Clin Neuropsychol; 2014; 28(2):252-68. PubMed ID: 24521259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    Mistridis P; Krumm S; Monsch AU; Berres M; Taylor KI
    J Alzheimers Dis; 2015; 48(4):1095-107. PubMed ID: 26402083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.